Skip to main content
. 2017 Feb 16;100(3):454–472. doi: 10.1016/j.ajhg.2017.01.030

Table 1.

Clinical and Molecular Data from FCDII-Affected Individuals Harboring TSC1 and TSC2 Mutations

Individual Age at Surgery Sex Pathology MRI Report Protein Nucleotide Change Protein Change % Mutated Allele
Hybrid Capture PCR Amplicon Sequencing
FCD 64 6 years, 9 months female cortical dyslamination and dysmorphic neurons (consistent with FCDIIa) cortical dysplasia involving the left frontoparietal lobe TSC1 c.610C>T p.Arg204Cys 1.75% 1.0%
FCD 81 12 years female cortical dyslamination and dysmorphic neurons (consistent with FCDIIa) no abnormal signal intensity TSC1 c.64C>T p.Arg22Trp 2.81% 2.0%
FCD 94 10 years, 3 months female cortical dyslamination and dysmorphic neurons (consistent with FCDIIa) subependymal heterotopia in the right peri-trigone area TSC2 c.4639G>A p.Val1547Ile 1.19% 1.55%
FCD 98 14 years, 3 months male cortical dyslamination and dysmorphic neurons (consistent with FCDIIa) no abnormal signal intensity TSC1 c.64C>T p.Arg22Trp 2.52% 1.98%
FCD 123 12 years, 4 months female cortical dyslamination, dysmorphic neurons, and balloon cells (consistent with FCDIIb) cortical dysplasia involving the right frontal lobe TSC1 c.64C>T p.Arg22Trp 2.21% 1.37%